AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ASHEVILLE, N.C. -- Peripartum hemorrhage is one of the leading causes of maternal mortality, making it important to understand the myriad options for controlling bleeding, David C. Mayer, M.D., said at the Southern Obstetric and Gynecologic Seminar.
"Unfortunately, over the decades, hemorrhage has never been moved out of the top three causes of maternal mortality," said Dr. Mayer of the department of anesthesiology at the University of North Carolina at Chapel Hill.
Peripartum hemorrhage accounts for as much as 18% of pregnancy-related deaths in the United States, according to one estimate.
Resuscitation is the first goal in the management of peripartum hemorrhage (PPH). Make sure there is an adequate number of intravenous lines and maintain adequate volume by using crystalloids, colloids, packed red blood cells, fresh frozen plasma, or platelets, as necessary. Get baseline blood laboratory tests, including a coagulation profile, and monitor arterial blood gas levels and urinary output. Invasive monitoring with arterial or central venous lines may be necessary, as may consultation with specialists, cautioned Dr. Mayer.
There are a number of options to control bleeding: pharmacologic (such as prostaglandins), autologous blood transfusion, and selective arterial embolization. Pharmacologic therapy includes oxytocics, ergot alkaloids, prostaglandins, and recombinant activated factor VII (rFVIIa). Keep in mind almost all studies of pharmacologic therapies are based on routine elective cesarean sections.
"It may have very little applicability to a patient with an atonic uterus," Dr. Mayer said.
Oxytocin (Pitocin) is the pharmacologic therapy that most obstetricians go to first to control bleeding. The drug can be used as prophylaxis in women who are at high risk for PPH, with doses of 10-40 U/L administered intravenously. "For uterine atony, I'm very aggressive with oxytocin, except for giving a large bolus," Dr. Mayer said during the meeting.